These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 33413466)

  • 21. Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer.
    Koleckova M; Ehrmann J; Bouchal J; Janikova M; Brisudova A; Srovnal J; Staffova K; Svoboda M; Slaby O; Radova L; Vomackova K; Melichar B; Veverkova L; Kolar Z
    Sci Rep; 2021 Mar; 11(1):5145. PubMed ID: 33664322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition.
    Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J
    Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer.
    Josson S; Gururajan M; Hu P; Shao C; Chu GY; Zhau HE; Liu C; Lao K; Lu CL; Lu YT; Lichterman J; Nandana S; Li Q; Rogatko A; Berel D; Posadas EM; Fazli L; Sareen D; Chung LW
    Clin Cancer Res; 2014 Sep; 20(17):4636-46. PubMed ID: 24963047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A step-by-step microRNA guide to cancer development and metastasis.
    Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E
    Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of epi-miRNA expression levels in local/locally advanced and metastatic prostate cancer patients.
    Gurbuz V; Kiliccioglu I; Dikmen AU; Bilen CY; Sozen S; Konac E
    Gene; 2020 Oct; 758():144963. PubMed ID: 32683077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205.
    Massoner P; Thomm T; Mack B; Untergasser G; Martowicz A; Bobowski K; Klocker H; Gires O; Puhr M
    Br J Cancer; 2014 Aug; 111(5):955-64. PubMed ID: 24992580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic Identification of MicroRNAs That Impact on Proliferation of Prostate Cancer Cells and Display Changed Expression in Tumor Tissue.
    Aakula A; Kohonen P; Leivonen SK; Mäkelä R; Hintsanen P; Mpindi JP; Martens-Uzunova E; Aittokallio T; Jenster G; Perälä M; Kallioniemi O; Östling P
    Eur Urol; 2016 Jun; 69(6):1120-8. PubMed ID: 26489476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
    Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
    Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CLCA2 epigenetic regulation by CTBP1, HDACs, ZEB1, EP300 and miR-196b-5p impacts prostate cancer cell adhesion and EMT in metabolic syndrome disease.
    Porretti J; Dalton GN; Massillo C; Scalise GD; Farré PL; Elble R; Gerez EN; Accialini P; Cabanillas AM; Gardner K; De Luca P; De Siervi A
    Int J Cancer; 2018 Aug; 143(4):897-906. PubMed ID: 29536528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells.
    Formosa A; Markert EK; Lena AM; Italiano D; Finazzi-Agro' E; Levine AJ; Bernardini S; Garabadgiu AV; Melino G; Candi E
    Oncogene; 2014 Oct; 33(44):5173-82. PubMed ID: 24166498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
    Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T
    Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do the expressions of epithelial-mesenchymal transition proteins, periostin, integrin-α4 and fibronectin correlate with clinico-pathological features and prognosis of metastatic castration-resistant prostate cancer?
    Konac E; Kiliccioglu I; Sogutdelen E; Dikmen AU; Albayrak G; Bilen CY
    Exp Biol Med (Maywood); 2017 Dec; 242(18):1795-1801. PubMed ID: 28836852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells.
    Liu C; Guan H; Wang Y; Chen M; Xu B; Zhang L; Lu K; Tao T; Zhang X; Huang Y
    PLoS One; 2015; 10(12):e0144073. PubMed ID: 26650737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The miR-218/GAB2 axis regulates proliferation, invasion and EMT via the PI3K/AKT/GSK-3β pathway in prostate cancer.
    Tian J; Zhang H; Mu L; Wang M; Li X; Zhang X; Xie E; Ma M; Wu D; Du Y
    Exp Cell Res; 2020 Sep; 394(1):112128. PubMed ID: 32522441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-150 suppresses epithelial-mesenchymal transition, invasion, and metastasis in prostate cancer through the TRPM4-mediated β-catenin signaling pathway.
    Hong X; Yu JJ
    Am J Physiol Cell Physiol; 2019 Apr; 316(4):C463-C480. PubMed ID: 30566393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
    Fuse M; Kojima S; Enokida H; Chiyomaru T; Yoshino H; Nohata N; Kinoshita T; Sakamoto S; Naya Y; Nakagawa M; Ichikawa T; Seki N
    J Hum Genet; 2012 Nov; 57(11):691-9. PubMed ID: 22854542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening and identification of epithelial-to-mesenchymal transition-related circRNA and miRNA in prostate cancer.
    Yan Z; Xiao Y; Chen Y; Luo G
    Pathol Res Pract; 2020 Feb; 216(2):152784. PubMed ID: 31882179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.
    Shukla P; Vogl C; Wallner B; Rigler D; Müller M; Macho-Maschler S
    BMC Genomics; 2015 Nov; 16():944. PubMed ID: 26572553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN.
    Duan XM; Liu XN; Li YX; Cao YQ; Silayiding A; Zhang RK; Wang JP
    Kaohsiung J Med Sci; 2019 Nov; 35(11):659-671. PubMed ID: 31332950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.